NEWGESIC-SPAS

Free

NEWGESIC-SPAS, a combination of Aceclofenac 100 mg and Drotaverine 80 mg, delivers sure-shot relief from painful spasms. Drotaverine’s targeted action on smooth muscles, coupled with Aceclofenac’s potent anti-inflammatory properties, ensures fast and effective relief from a range of spasm-related conditions, including smooth muscle spasm, post-surgical spasm, spastic constipation, and spasmodic dysmenorrhoea. This combination therapy is well-tolerated, with minimal adverse effects, making it a reliable choice for patients seeking comprehensive and prompt relief.

Category: Tag:

Description

Product Features

  • Active Ingredients: Aceclofenac 100 mg + Drotaverine 80 mg
  • Mechanism of Action:
    • Drotaverine: Provides direct, specific, and fast action on smooth muscles, helping to alleviate spasms.
    • Aceclofenac: An anti-inflammatory agent that effectively relieves pain by reducing inflammation.

Product Details

  • Brand Name: NEWGESIC-SPAS
  • Formulation: Tablet
  • Dosage: 100 mg of Aceclofenac and 80 mg of Drotaverine per tablet
  • Packaging: Typically available in blister packs

Benefits

  • Combination Therapy:
    • The combination of Aceclofenac and Drotaverine offers superior relief from painful spasms compared to monotherapy.
    • Provides both pain relief and antispasmodic effects, ensuring comprehensive management of symptoms.
  • Safety & Tolerability:
    • Minimal reported adverse effects.
    • Suitable for a wide range of patients needing relief from spasms and associated pain.

Indications

  • Smooth Muscle Spasm: Effective in treating spasms of smooth muscles, providing quick relief.
  • Post-Surgical Spasm: Alleviates spasms that may occur following surgical procedures.
  • Spastic Constipation: Helps manage constipation caused by muscle spasms in the digestive tract.
  • Spasmodic Dysmenorrhoea: Provides relief from painful menstrual cramps caused by uterine spasms.

Reviews

There are no reviews yet.

Be the first to review “NEWGESIC-SPAS”

Your email address will not be published. Required fields are marked *